These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11908186)

  • 21. [Therapy of Kawasaki disease in the acute phase: steroid and aspirin therapy].
    Kato H; Ichinose E
    Nihon Rinsho; 1983 Sep; 41(9):2092-6. PubMed ID: 6663745
    [No Abstract]   [Full Text] [Related]  

  • 22. Selection of high-risk children for immunoglobulin therapy in Kawasaki disease.
    Iwasa M; Sugiyama K; Ando T; Nomura H; Katoh T; Wada Y
    Prog Clin Biol Res; 1987; 250():543-4. PubMed ID: 3423068
    [No Abstract]   [Full Text] [Related]  

  • 23. [How does the time of diagnosis affect the course of disease in children with kawasaki syndrome? A retrospective analysis at one center].
    Raith W; Gamillscheg A; Heinzl B; Nagel BH; Koestenberger M; Beitzke A
    Klin Padiatr; 2009; 221(2):83-8. PubMed ID: 19263328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Kawasaki disease in adult].
    Forsberg S; Rainio A
    Duodecim; 1996; 112(21):2015-8. PubMed ID: 10605202
    [No Abstract]   [Full Text] [Related]  

  • 25. Kawasaki disease resistant to immunoglobulin G therapy.
    Venugopalan P; Jaya S; Al-Azri MA; Piopongco E
    Ann Trop Paediatr; 2003 Sep; 23(3):187-91. PubMed ID: 14567834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Kawasaki disease.
    Inoue Y; Kobayashi T; Morikawa A
    N Engl J Med; 2007 Jun; 356(26):2746-7; author reply 2748. PubMed ID: 17596613
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical evaluation of gammaglobulin preparations for the treatment of Kawasaki disease.
    Ogino H; Ogawa M; Harima Y; Kono S; Ohkuni H; Nishida M; Kobayashi Y; Yabuuchi H
    Prog Clin Biol Res; 1987; 250():555-6. PubMed ID: 3321085
    [No Abstract]   [Full Text] [Related]  

  • 28. Images in cardiovascular medicine. Giant coronary artery aneurysms in Kawasaki disease.
    Lilje C; Joyce JJ
    Circulation; 2005 Jun; 111(24):e440. PubMed ID: 15967855
    [No Abstract]   [Full Text] [Related]  

  • 29. Is there a role for corticosteroids in Kawasaki disease?
    Shulman ST
    J Pediatr; 2003 Jun; 142(6):601-3. PubMed ID: 12838185
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T; Kishiro M; Akimoto K; Nagata S; Shimizu T; Yamashiro Y
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary cytomegalovirus infection, atypical Kawasaki disease, and coronary aneurysms in 2 infants.
    Catalano-Pons C; Quartier P; Leruez-Ville M; Kaguelidou F; Gendrel D; Lenoir G; Casanova JL; Bonnet D
    Clin Infect Dis; 2005 Sep; 41(5):e53-6. PubMed ID: 16080076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strengthening the case for primary adjunctive corticosteroids for Kawasaki disease.
    Renton WD; Ramanan AV
    Arch Dis Child; 2021 Mar; 106(3):209-210. PubMed ID: 33272947
    [No Abstract]   [Full Text] [Related]  

  • 34. Infliximab as a novel therapy for refractory Kawasaki disease.
    Weiss JE; Eberhard BA; Chowdhury D; Gottlieb BS
    J Rheumatol; 2004 Apr; 31(4):808-10. PubMed ID: 15088313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kawasaki disease--a continuing puzzle.
    Neches WH
    Int J Cardiol; 1986 Apr; 11(1):1-7. PubMed ID: 3514482
    [No Abstract]   [Full Text] [Related]  

  • 36. Kawasaki syndrome, Reye syndrome, and aspirin.
    Takahashi M; Mason W
    Pediatrics; 1986 Apr; 77(4):616-7. PubMed ID: 3960631
    [No Abstract]   [Full Text] [Related]  

  • 37. [The Kawasaki syndrome].
    De Benedetto F; Vena N
    Minerva Pediatr; 1982 Oct; 34(20):875-7. PubMed ID: 7155097
    [No Abstract]   [Full Text] [Related]  

  • 38. Intravenous gamma globulin therapy in Kawasaki disease--trial of low dose gamma globulin.
    Okuni M; Harada K; Yamaguchi H; Yanagawa H; Sonobe T; Kawasaki T
    Prog Clin Biol Res; 1987; 250():433-9. PubMed ID: 3321083
    [No Abstract]   [Full Text] [Related]  

  • 39. Enzyme release and O2 production of neutrophils and vascular lesions in gamma globulin therapy of Kawasaki disease.
    Okazaki T; Sakatani T; Sasagawa S; Ohta H; Ohnishi H; Suzuki K
    Prog Clin Biol Res; 1987; 250():557-8. PubMed ID: 3423073
    [No Abstract]   [Full Text] [Related]  

  • 40. Kawasaki disease or mucocutaneous lymph node syndrome. Has it a microbial aetiology?
    J Infect; 1984 Jul; 9(1):1-5. PubMed ID: 6501892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.